Recent Finacing
Recent Raise
Armo BioSciences is a clinical-stage biotechnology company developing IL-10-based immunotherapies (AM0010) and checkpoint/cytokine programs to activate CD8+ T cells across pancreatic, NSCLC, RCC, melanoma and colorectal cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors